Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results
(MedPage Today) -- Two first-line trials involving pembrolizumab (Keytruda)-based combinations for the treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) delivered mixed results.
While first-line pembrolizumab plus... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 1, 2024 Category: Hematology Source Type: news
Inadequate Knowledge: HPV and Oropharyngeal Carcinoma Inadequate Knowledge: HPV and Oropharyngeal Carcinoma
Dr Maurie Markman discusses a recent paper investigating knowledge about the relationship between HPV and oropharyngeal squamous cell carcinoma.Medscape Oncology (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 29, 2024 Category: Infectious Diseases Tags: Hematology-Oncology Commentary Source Type: news
Do we recognize oral cancer? Primary professional delay in diagnosis of oral squamous cell carcinoma
ConclusionsOSCC patients seek care actively. Primary professional delay affects the care of every tenth OSCC patient.Clinical relevanceThe
role of health care professionals is essential for early OSCC
diagnosis, especially in urgent care. Clinicians ’ knowledge of the
typical symptoms and findings of OSCC should be improved. (Source: Dental Technology Blog)
Source: Dental Technology Blog - February 14, 2024 Category: Dentistry Source Type: news
Why Is HOOKIPA Pharma Stock Trading Lower Today?
HOOKIPA Pharma Inc HOOK will focus its resources on prioritizing the clinical development of a randomized trial for its HB-200 program in human papillomavirus 16 positive (HPV16+) head and neck squamous cell carcinoma (HNSCC) and its two Gilead Science Inc GILD-partnered infectious disease cure…#hookipapharmainchook #gileadscienceinc #hookipa #rocheholdingsag #rhhby #kras #gileadsciences #gilead (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2024 Category: Consumer Health News Source Type: news
Adding Immunotherapy, Anti-TIGIT in First Line Boosts OS in Esophageal Cancer
(MedPage Today) -- SAN FRANCISCO -- Adding the novel anti-TIGIT monoclonal antibody tiragolumab plus atezolizumab (Tecentriq) to standard first-line chemotherapy significantly improved survival for patients with advanced esophageal squamous cell... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 20, 2024 Category: Gastroenterology Source Type: news
Community Cancer Centers Treating More HPV-Related Head, Neck Cancer
THURSDAY, Jan. 11, 2024 -- Treatment of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma has recently shifted to community cancer centers, with an increase in the proportion of nonsurgical treatment and worse overall... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2024 Category: Pharmaceuticals Source Type: news
Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras
(MedPage Today) -- Using language that minimizes adverse events in studies presented at oncology conferences could compromise patient care. (Journal of Cancer Policy)
While care for patients with human papillomavirus (HPV)-related squamous cell... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 5, 2024 Category: Hematology Source Type: news
Why Is Cancer Focused CEL-SCI Stock Trading Higher Today?
CEL-SCI Corporation CVM announced that the British National Institute for Health and Care Excellence (NICE) has selected Multikine (Leukocyte Interleukin, Injection) to be evaluated as the potential new standard of care for squamous cell carcinoma of the head and neck (SCCHN) in the U.K. The NICE…#celscicorporationcvm #leukocyteinterleukin #multikine #geertkersten (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2023 Category: Consumer Health News Source Type: news
Mayo Clinic study suggests lower extremity lymphedema is a risk factor for multiple types of skin cancer
ROCHESTER, Minn. — New research from Mayo Clinic finds that patients with lymphedema —swelling of the limbs caused by the accumulation of protein-rich fluids of the immune system — had twice the risk of developing skin cancer than patients without lymphedema. Patients with lymphedema had a significantly higher frequency of developing basal cell carcinomas and squamous cell carcinomas on the lower extremities, according to the retrospective study published in Mayo Clinic Proceedings. The study contributes… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 9, 2023 Category: Databases & Libraries Source Type: news
Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis
(MedPage Today) -- Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 2, 2023 Category: Hematology Source Type: news
Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC
(MedPage Today) -- MADRID -- Treatment with cemiplimab (Libtayo) followed by surgery showed encouraging survival rates in patients with resectable stage II-IV cutaneous squamous cell carcinoma (SCC), according to follow-up results from a small... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 26, 2023 Category: Dermatology Source Type: news
Lunit to showcase AI research at ESMO 2023
AI developer Lunit will present nine studies featuring the company's AI pathology technology at the upcoming European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain, being held October 20 to 24, 2023.The abstracts will cover a variety of areas and include the following:AI for prediction of multiple druggable mutations in non-small cell lung cancer from H&E stained imagesLunit Scope IO for distinguishing mismatch repair deficiency from mismatch repair proficiency colon cancers by analyzing features in whole slide imagesAI investigating the efficacy and safety of avelumab plus gemcitabine in leiomyosarcom...
Source: AuntMinnie.com Headlines - October 10, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Good Oral Health Linked to Improved Survival in Head & Neck Cancer
FRIDAY, Sept. 22, 2023 -- For patients with head and neck squamous cell carcinoma, good oral health is associated with improved survival, according to a study published online Sept. 19 in the Journal of the National Cancer Institute.
Jason Tasoulas,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2023 Category: Pharmaceuticals Source Type: news
Can Skin Bleaching Lead to Cancer? Can Skin Bleaching Lead to Cancer?
The use of skin-lightening products is associated with a wide range of complications. Is squamous cell carcinoma one of them?Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 11, 2023 Category: Internal Medicine Tags: Dermatology News Source Type: news
